Delivery Order SPE2DB22D3301-SPE2DB24FZ2GT

Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Lo Loestrin Fe 1-10 Tablet 28s, a pharmaceutical product. The delivery order has a ceiling value of $9,475.77 and a period of performance through August 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The delivery order, valued at $12,346.37, is for the supply of Lo Loestrin Fe 1-10 tablet medication. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,098.24 firm-fixed-price contract is for the provision of Lo Loestrin Fe 1-10 tablet 28s, a birth control medication. The contract has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lo Loestrin Fe 1-10 tablet 28s. The $1,647.36 firm fixed-price contract has a completion date of September 19, 2024. It is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $6,395.92 firm fixed price contract is for the supply of the pharmaceutical product LO LOESTRIN FE 1-10 TABLET 28S. This delivery order is under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,077.38 firm fixed-price contract is for the delivery of 4,558,921,410 units of the contraceptive medication LO LOESTRIN FE 1-10 Tablet 28s. The contract has an ultimate completion date of October 31, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor, to provide Lo Loestrin Fe 1-10 tablet 28s. The order has a ceiling value of $39,912.13 and an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. This delivery order is one of many that...
This contract award to AmerisourceBergen Drug Corp is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical, with a firm fixed price ceiling of $1,098.24 and a period of performance through September 9, 2024. The contract covers the procurement of 4,565,714,337 units of the prescription medication Lo Loestrin Fe 1-10 Tablet 28s. This contract is not designated as a set-aside. AmerisourceBergen is a major pharmaceutical distributor that holds two Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,593.18 firm fixed-price delivery order is for the supply of the prescription medication Lo Loestrin Fe 1-10 Tablet 28s. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,452.13 firm fixed price delivery order is for the supply of Lo Loestrin FE 1-10 Tablet 28s, a medication. The award was made on September 26, 2024, with a completion date of September 27, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2GT
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The order, valued at $7,239.65, is for the supply of the medication Lo Loestrin Fe 1-10 Tablet 28s. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by August 7, 2024.

Generated 11/5/24, 9:30 AM